Nikhil Prasad Fact checked by:Thailand Medical News Team Jan 19, 2025 3 hours, 56 minutes ago
Medical News: Echinacea, a well-known herb celebrated for its immune-boosting properties, has long been a staple in traditional and modern medicine. Native to North America and historically used by Great Plains tribes like the Lakota and Sioux, Echinacea was once a remedy for ailments ranging from respiratory infections to wounds and even snake bites. In the late 1800s, it gained popularity through commercial tinctures and became a favored remedy before antibiotics took center stage. Now, thanks to modern research, Echinacea is making a significant comeback.
Alkylamides from Echinacea Shows Promising Effects Against Respiratory Viruses
Recently, a groundbreaking study led by researchers from the Ric Scalzo Institute for Botanical Research at the Sonoran University of Health Sciences in Arizona-USA explored the antiviral and immune-modulatory properties of Echinacea purpurea. The findings could herald a new era for treating respiratory viruses, especially the common cold and flu.
The Study and Its Objectives
The research aimed to evaluate the effects of Echinacea purpurea extracts and specific alkylamides (phytochemical compounds found in the plant’s roots) on respiratory virus replication and immune responses. With respiratory illnesses causing billions of dollars in economic losses annually and posing risks to vulnerable populations, the need for effective treatments has never been greater. This
Medical News report delves into the study’s key findings and their implications.
Understanding Alkylamides and Their Role
Alkylamides are lipophilic compounds in Echinacea known for their immune-modulatory and anti-inflammatory properties. Among these, a specific alkylamide - dodeca-2E,4E-dienoic acid isobutylamide - stood out in this study for its significant antiviral activity against rhinovirus and influenza virus. These viruses are the primary culprits behind common colds and flu.
The study utilized a series of in vitro experiments, testing Echinacea extracts and individual alkylamides on infected cells. Researchers observed that the Echinacea extract effectively inhibited viral replication at relatively low concentrations, with complete inhibition achieved at higher doses. Among the alkylamides tested, dodeca-2E,4E-dienoic acid isobutylamide demonstrated the most potent antiviral effects.
Key Findings on Antiviral Activity
-Rhinovirus and Influenza Virus Inhibition: The Echinacea root extract showed strong inhibitory effects on both rhinovirus and influenza virus replication. Viral plaque assays revealed a dose-dependent reduction in viral activity, with significant inhibition observed even at moderate concentrations.
-Alkylamide D’s Potency: Of the alkylamides tested, alkylamide D (dodeca-2E,4E-dienoic acid isobutylamide) exhibited exceptional antiviral activity. It achieved an IC50 (the concentration needed to inhibit 50% of viral activity) significantly lower than other compounds,
making it a prime candidate for further therapeutic exploration.
-Immune Modulation Through IL-8 Suppression: In addition to its antiviral properties, alkylamide D effectively reduced IL-8 cytokine production. IL-8 is a signaling protein that recruits immune cells to infection sites but is also responsible for inflammation and many cold symptoms. By suppressing IL-8, alkylamide D not only fights the virus but also alleviates associated symptoms.
Broader Implications of the Findings
The study’s results have profound implications for respiratory virus treatment. Unlike antibiotics, which are ineffective against viral infections, Echinacea’s active compounds offer a dual approach: directly inhibiting virus replication and modulating immune responses to reduce inflammation. This could lead to shorter illness durations and milder symptoms.
Furthermore, the low cytotoxicity observed in the experiments suggests that Echinacea and its compounds are safe for human use at therapeutic doses. The selectivity index (SI), a measure of a compound’s safety and efficacy, was remarkably high for alkylamide D. This reinforces its potential as a viable treatment option.
The Path to Clinical Applications
While these findings are promising, translating them into clinical applications requires further investigation. The study was conducted in vitro, meaning the effects were observed in a controlled laboratory environment using cultured cells. Clinical trials involving human participants are the next crucial step to confirm these benefits and determine appropriate dosages and formulations.
Moreover, standardization of Echinacea extracts will be essential. Variability in plant species, growing conditions, and extraction methods can lead to inconsistent concentrations of active compounds. Establishing standardized protocols will ensure the reproducibility and reliability of therapeutic products.
Conclusion and Future Directions
The research conducted by the team at the Ric Scalzo Institute for Botanical Research has shed light on the potential of Echinacea purpurea as a powerful tool against respiratory viruses. By targeting both viral replication and inflammatory pathways, Echinacea offers a comprehensive approach to managing common colds and flu. These findings pave the way for more natural and accessible treatments, potentially reducing the burden on healthcare systems and improving quality of life for millions worldwide.
Future studies should focus on conducting large-scale clinical trials, exploring the synergistic effects of Echinacea’s various compounds, and developing standardized formulations for widespread use. If these efforts succeed, Echinacea could reclaim its historical status as a go-to remedy for respiratory illnesses in the modern era.
The study findings were published in the peer-reviewed journal: Molecules.
https://www.mdpi.com/1420-3049/30/2/386
For the latest on Herbs and Phytochemicals, keep on logging to
Thailand Medical News.
Read Also:
https://www.thailandmedical.news/news/findings-of-a-randomized-clinical-trial-that-explored-the-potential-of-echinacea-for-covid-19
https://www.thailandmedical.news/news/randomized-clinical-trial-studies-show-that-echinacea-is-effective-against-a-variety-of-coronavirus-infections-including-sars-cov-2
https://www.thailandmedical.news/news/breaking-european-randomized-clinical-study-shows-that-echinacea-reduces-risk-of-viral-respiratory-tract-infections-including-covid-19
https://www.thailandmedical.news/news/covid-19-herbs-saudi-arabia-study-demonstrates-possible-use-of-echinacea-and-st-john-s-wort-as-therapeutic-agents-against-covid-19
https://www.thailandmedical.news/news/breaking-coronavirus-research-could-echinacea-act-as-a-prophylaxis-against-the-sars-cov-2-coronavirus-more-research-warranted
Share
Tweet
Share
